Canadian Platform to Offer India-Sourced Ozempic to US
A Canadian pharmacy platform plans to supply US patients with Ozempic sourced from India starting in 2026, creating a new cross-border pharmaceutical channel. Learn the details and implications.
A Canadian pharmacy platform plans to supply US patients with Ozempic sourced from India starting in 2026, creating a new cross-border pharmaceutical channel. Learn the details and implications.
Eupraxia Pharmaceuticals reveals consistent 52-week data from RESOLVE trial, showing EP-104GI maintains clinical remission in eosinophilic esophagitis patients with strong safety profile.
Health Canada refuses to explain how $20 million worth of pharmaceuticals vanished from national emergency stockpile. Transparency concerns raised.